Results 201 to 210 of about 156,077 (286)

Risk of opioid overdose during buprenorphine treatment for opioid use disorder in the fentanyl era. [PDF]

open access: yesAddict Behav
Chambers LC   +9 more
europepmc   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

open access: yesAllergy, Volume 81, Issue 9, Page 3039-3070, September 2026.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
Franziska Roth‐Walter   +20 more
wiley   +1 more source

Clinical factors linked to xylazine exposure in emergency department patients with illicit opioid overdose. [PDF]

open access: yesAddiction
Love JS   +12 more
europepmc   +1 more source

Technology‐Driven Decision Support for Opioid Tapering: A Scoping Review

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 139, Issue 3, September 2026.
ABSTRACT Background General practitioners manage most opioid tapering. This process requires time‐consuming, individualised planning accounting for patient preferences, dose options and costs. Consequently, clinicians need tools to support tapering.
Laurits Valberg Hemmingsen   +3 more
wiley   +1 more source

Peripheral κ opioid receptor in pain and inflammation: From molecular signalling and gene expression to drug discovery

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 17, Page 5157-5189, September 2026.
The κ opioid receptor (κ receptor, KOR) is a G protein‐coupled receptor with well established roles in analgesia and immune modulation. Although historically studied primarily in the central nervous system (CNS), growing evidence indicates that κ signalling in peripheral tissues plays an important role in regulating pain, inflammation and immune ...
Rumsha Khan   +3 more
wiley   +1 more source

Inhibition of kynurenine 3‐monooxygenase (KMO) reduces fentanyl and sucrose intake and relapse‐like behaviour in rats

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 18, Page 5458-5475, September 2026.
Abstract Background and Purpose Opioid use disorder, particularly involving fentanyl, poses major challenges due to high relapse rates and limited effectiveness of pharmacotherapies. The kynurenine pathway has emerged as a target for addiction treatment through its modulation of glutamatergic and dopaminergic neurotransmission.
Carlos Núñez‐de la Calle   +12 more
wiley   +1 more source

New persistent opioid use after colorectal surgery in Sweden: A nationwide register‐based cohort study

open access: yesColorectal Disease, Volume 28, Issue 9, September 2026.
Abstract Aim To determine the incidence of new persistent opioid use (NPOU) after elective colorectal surgery in Sweden and to identify associated patient‐, procedure‐ and hospital‐level factors. Method This nationwide retrospective cohort study linked data from Swedish national health registries and included adults undergoing elective inpatient ...
Claes Gedda   +5 more
wiley   +1 more source

Cost-effectiveness of community-based interventions for reducing opioid overdose and non-overdose deaths: simulation modeling of HEALing Communities Study. [PDF]

open access: yesLancet Reg Health Am
Chhatwal J   +24 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy